A compilation of hundreds of U.S. nuclear sites and activities that were to be declared to the International Atomic Energy Agency by the United States was transmitted to Congress last month by President Obama.
“The enclosed draft declaration lists each site, location, facility, and activity I intend to declare to the IAEA, and provides a detailed description of such sites, locations, facilities, and activities, and the provisions of the U.S.-IAEA Additional Protocol under which they would be declared,” the President wrote. “Each site, location, facility, and activity would be declared in order to meet the obligations of the United States of America with respect to these provisions.”
“The IAEA classification of the enclosed declaration is ‘Highly Confidential Safeguards Sensitive’,” the President noted in his May 5, 2009 transmittal letter, “however, the United States regards this information as ‘Sensitive but Unclassified’.”
But sensitive or not, the draft declaration was promptly published by the Government Printing Office. See “The List of Sites, Locations, Facilities, and Activities Declared to the International Atomic Energy Agency,” message from the President of the United States, May 6, 2009 (267 pages, 13 MB PDF file).
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.